Brain Tunnelgenix

Executive Summary

Brain Tunnelgenix Technologies Corp (BTT Corp) is a San Diego-based private neuroscience and diagnostics company that has developed the Brain Thermal Tunnel (BTT) technology—a first-of-its-kind, non-invasive, continuous wearable system for monitoring human brain temperature. Founded in 2015, the company aims to address critical unmet needs in neurodegenerative disease management (e.g., Alzheimer's, Parkinson's, traumatic brain injury) and general wellness by providing real-time, accurate brain temperature data. Unlike invasive or spot-check methods, BTT's platform enables continuous monitoring in everyday settings, potentially enabling early detection of temperature dysregulation linked to neurological conditions. The technology is protected by intellectual property and has garnered initial interest from research institutions. While the company remains private and early-stage, its differentiated approach to brain health monitoring could disrupt both clinical diagnostics and consumer wellness markets. Key risks include validation through clinical studies, regulatory clearance, and commercialization execution. The company has not disclosed funding or valuation, but its proprietary platform positions it well for partnerships with pharmaceutical companies, research centers, and health systems.

Upcoming Catalysts (preview)

• Q1 2027Initiation of first clinical trial for neurodegenerative disease monitoring30% success
• Q2 2027Strategic partnership or licensing deal with a pharmaceutical or medical device company35% success
• Q4 2027FDA 510(k) clearance for initial commercial launch25% success